Crossref
Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone
European Journal of Cancer · 2026-03 · 237 · 116522
DOI: 10.1016/j.ejca.2026.116522 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-03. Verfasst von K. Pinnell und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pinnell, K., Finegan, K., Williams, K., & Cartmell, S. (2026). Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone. European Journal of Cancer, 237, 116522. https://doi.org/10.1016/j.ejca.2026.116522
Vancouver
Pinnell K, Finegan K, Williams K, Cartmell S. Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone. European Journal of Cancer. 2026;237:116522. doi:10.1016/j.ejca.2026.116522
BibTeX
@article{Pinnell2026,
author = {Pinnell, K. and Finegan, K. and Williams, K. and Cartmell, S.},
title = {Targeting ERK5 as a novel approach to ameliorate breast cancer metastasis to the bone},
journal = {European Journal of Cancer},
year = {2026},
volume = {237},
pages = {116522},
doi = {10.1016/j.ejca.2026.116522}
}
EUVIMED